In addition, Dyrk1A maintains cancer cells in a quiescence state through the formation of the DREAM complex, which maintains cells in a noncycling G0 phase by stabilizing p27Kip1, a cyclin-dependent kinase (CDK) inhibitor, and finally through inducing the degradation of cyclin D isoforms [16]. This evidence concerns the gene DYRK1A and cancer.